PROTACs in Epigenetic Cancer Therapy: Current Status and Future Opportunities.

Liu, Xuelian; Wang, Anjin; Shi, Yuying; Dai, Mengyuan; Liu, Miao; Cai, Hong-Bing

Liu, Xuelian; Wang, Anjin; Shi, Yuying; Dai, Mengyuan; Liu, Miao; Cai, Hong-Bing.

Afiliação

Liu X; Department of Gynecological Oncology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
Wang A; Hubei Key Laboratory of Tumor Biological Behaviors, Wuhan 430071, China.
Shi Y; Hubei Cancer Clinical Study Center, Wuhan 430071, China.
Dai M; Department of Gynecological Oncology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
Liu M; Hubei Key Laboratory of Tumor Biological Behaviors, Wuhan 430071, China.
Cai HB; Hubei Cancer Clinical Study Center, Wuhan 430071, China.

Molecules ; 28(3)2023 Jan 26.

Article em En | MEDLINE | ID: mdl-36770884

Assuntos

Epigênese Genética; Neoplasias; Proteólise; Complexo de Endopeptidases do Proteassoma; Citoplasma; Epigenoma; Neoplasias/tratamento farmacológico; Neoplasias/genética

Palavras-chave

PROTACs; cancer therapy; epigenetics; protein degradation

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Epigênese Genética / Neoplasias Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google